French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

The holiday season brings joy, togetherness, and abundant sweet temptations. While pies, cookies, and cakes dominate festive ...

Egyptian Drug AuthorityThe Ministry of Health launched the country’s first locally produced long-acting insulin on 17 ...

Type 1 diabetes develops when the body destroys its own insulin-producing cells. Using stem cells to replace them could be a ...

The long-acting insulin, which will treat millions of diabetes patients, is the result of a 2022 partnership between Egyptian ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Conclusions—Demonstration of persistence and function of insulin-producing pancreatic cells suggests the possibility of a steady state of turnover in which stimuli to enhance endogenous β cells ...

French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a local authority in the city said on Monday, citing a memorandum of ...

After struggling with weight gain for three years, Sarah Bisacca was diagnosed with insulin resistance. Here's how she was ...